Metraipolis › archive › dc_a379da37f2f6

Complement C5 inhibition in generalized myasthenia gravis is associated with improved survival and increased cardiovascular risk — Europe PMC PMID:42220523

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42220523
DOI
10.3389/fimmu.2026.1812643
License (as archived)
solo-consultazione
Archived
2026-11-02T08:28:26.487Z
SHA-256 of the archived text
e6208e1d1c16d8126260a36d8eb25585ea63373ddc450d9e34690e840bacb0ac
Stable URL of this page
https://metraipolis.com/documento/dc_a379da37f2f6

How to cite

Complement C5 inhibition in generalized myasthenia gravis is associated with improved survival and increased cardiovascular risk — Europe PMC PMID:42220523 — Europe PMC (en), https://europepmc.org/article/MED/42220523 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a379da37f2f6 (Metraipolis archive dc_a379da37f2f6, sha256 e6208e1d1c16d8126260a36d8eb25585ea63373ddc450d9e34690e840bacb0ac)
BibTeX
@misc{dca379da37f2f6,
  title = {Complement C5 inhibition in generalized myasthenia gravis is associated with improved survival and increased cardiovascular risk — Europe PMC PMID:42220523},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42220523},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a379da37f2f6; sha256 e6208e1d1c16d8126260a36d8eb25585ea63373ddc450d9e34690e840bacb0ac},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42220523. Agents can read the archived copy with the MCP tool read_document.